Skip to main content

4 Result(s)

within G. M. Mead Remove this filter Biomedicine, general Remove this filter

and
Your search also matched 3 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Second look laparotomy in the management of epithelial cell carcinoma of the ovary

Include preview-only content

  1. Article

    Open Access

    Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

    The aim of this study was to define prognostic parameters for survival in patients with malignant germ cell tumours progressing after platinum-based induction chemotherapy with or without surgery. A total of 1...

    S D Fosså, S P Stenning, A Gerl, A Horwich, P I Clark… in British Journal of Cancer (1999)

    Download PDF (279 KB)

  2. Article

    Open Access

    A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma

    The UK Medical Research Council conducted this trial of carboplatin chemotherapy in advanced seminoma to compare single agent carboplatin with a standard combination of etoposide with cisplatin. The use of sin...

    A Horwich, R T D Oliver, P M Wilkinson, G M Mead, S J Harland… in British Journal of Cancer (2000)

    Download PDF (203 KB)

  3. Article

    Open Access

    Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

    Adjuvant BEP (bleomycin, etoposide, cisplatin) is effective treatment for high-risk clinical stage I (HRCS1) non-seminomatous germ cell tumours (NSGCT), but the known toxicities of etoposide, and the expansion...

    D P Dearnaley, S D Fossa, S B Kaye, M H Cullen, S J Harland… in British Journal of Cancer (2005)

    Download PDF (147 KB) View Article

  4. Article

    Open Access

    A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial

    This phase II trial describes the use of TIP chemotherapy (paclitaxel, ifosfamide and cisplatin) as salvage for patients with metastatic germ cell cancer (GCC) who have failed initial BEP (bleomycin, etoposide...

    G M Mead, M H Cullen, R Huddart, P Harper, G J S Rustin… in British Journal of Cancer (2005)

    Download PDF (134 KB) View Article